Stereotactic Post-operative Radiotherapy for Intraparotid Metastatic Cutaneous Squamous Cell Carcinoma

The purpose of this study is to compare the effectiveness and side effects of stereotactic radiotherapy (5 sessions) against conventional (standard) radiotherapy (20-30 sessions) for the treatment of skin cancer involving the head and neck after surgical resection. Stereotactic radiotherapy works in the same way that conventional (standard) radiotherapy does to kill cancer cells by damaging their genetic material and stopping the cancer cells from making copies of themselves. This study will help the study doctors find out if this different approach is the same, better, or worse than the sta

Trial Details

NCT ID
NCT07337161
Phase
NA
Sponsor
David Palma
Status
RECRUITING
Cancer Type
Head and Neck Cancer
Interventions
  • SBRT
  • Standard Radiation
Locations (sample)
  • London, Ontario, Canada|42.98339,-81.23304

Key Eligibility Criteria

  • Age ≥ 18 years
  • Patient able to provide informed consent
  • Eastern Cooperative Oncology Group (ECOG) performance status 0-2
  • Patient is a candidate for curative intent treatment

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Head and Neck Cancer Trials on Trialify →